Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Vanda Pharmaceuticals
Related studies linked through entity extraction aliases.
Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin.
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics of Tasimelteon in Subjects With Renal Impairment and Matched Control Subjects With Relatively Normal Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
- Status
- COMPLETED
- Phase
- PHASE3
Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Relapse Prevention Study in Patients With Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Patient Registry of Blind Subjects With Sleep-related Problems
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
- Status
- COMPLETED
- Phase
- PHASE3
VEC-162 Study in Adult Patients With Primary Insomnia
- Status
- COMPLETED
- Phase
- PHASE3